Prognostic values of systemic inflammatory immunological markers in glioblastoma: A systematic review and meta-analysis

P Jarmuzek, K Kozlowska, P Defort, M Kot… - Cancers, 2023 - mdpi.com
Simple Summary The authors report the most up-to-date review and a thorough meta-
analysis of inflammatory, immunological markers such as neutrophil-to-lymphocyte ratio …

Macrophages in recurrent glioblastoma as a prognostic factor in the synergistic system of the tumor microenvironment

N Montemurro, B Pahwa, A Tayal, A Shukla… - Neurology …, 2023 - mdpi.com
Glioblastoma (GBM) is a common and highly malignant primary tumor of the central nervous
system in adults. Ever more recent papers are focusing on understanding the role of the …

Cell-free miRNAs as non-invasive biomarkers in brain tumors

O Beylerli, MJ Encarnacion Ramirez, A Shumadalova… - Diagnostics, 2023 - mdpi.com
Diagnosing brain tumors, especially malignant variants, such as glioblastoma,
medulloblastoma, or brain metastasis, presents a considerable obstacle, while current …

Prognostic value of systemic immune-inflammation index (SII) in patients with glioblastoma: A comprehensive study based on meta-analysis and retrospective single …

C Yang, BW Hu, F Tang, Q Zhang, W Quan… - Journal of Clinical …, 2022 - mdpi.com
Inflammation is related to cancer. The systemic immune-inflammation index (SII) has been
linked to the prognosis of many types of cancer. The present study aimed to determine the …

Prognostic role of the pretreatment systemic immune-inflammation index in patients with glioma: A meta-analysis

S Zhang, Q Ni - Frontiers in Neurology, 2023 - frontiersin.org
Background The systemic immune-inflammation index (SII) has been recognized as the
indicator that reflects the status of immune responses. The SII is related to the prognostic …

The prognostic impact of gender, therapeutic strategies, molecular background, and tumor-infiltrating lymphocytes in glioblastoma: a still unsolved jigsaw

L Innocenti, V Ortenzi, R Scarpitta, N Montemurro… - Genes, 2023 - mdpi.com
Despite the adoption of novel therapeutical approaches, the outcomes for glioblastoma
(GBM) patients remain poor. In the present study, we investigated the prognostic impact of …

Immuno markers in newly diagnosed glioblastoma patients underwent Stupp protocol after neurosurgery: a retrospective series

L Gurrieri, L Mercatali, T Ibrahim, V Fausti… - Journal of Neuro …, 2023 - Springer
Purpose The aims of our retrospective study investigated the role of immune system in
glioblastoma (GBM), which is the most aggressive primary brain tumor in adults …

Forkhead box transcription factors (FOXOs and FOXM1) in glioma: from molecular mechanisms to therapeutics

P Tabnak, A Hasanzade Bashkandi… - Cancer Cell …, 2023 - Springer
Glioma is the most aggressive and malignant type of primary brain tumor, comprises the
majority of central nervous system deaths, and is categorized into different subgroups …

Multiparametric longitudinal profiling of RCAS-tva-Induced PDGFB-driven experimental glioma

H Becker, S Castaneda-Vega, K Patzwaldt, JM Przystal… - Brain Sciences, 2022 - mdpi.com
Glioblastomas are incurable primary brain tumors harboring a heterogeneous landscape of
genetic and metabolic alterations. Longitudinal imaging by MRI and [18F] FET-PET …

A Novel necroptosis-related prognostic signature of Glioblastoma Based on Transcriptomics Analysis and single cell sequencing analysis

Y Wu, Y Huang, C Zhou, H Wang, Z Wang, J Wu, S Nie… - Brain Sciences, 2022 - mdpi.com
Background: Glioblastoma (GBM) is the most common and deadly brain tumor. The clinical
significance of necroptosis (NCPS) genes in GBM is unclear. The goal of this study is to …